Geode Capital Management’s Sensei Biotherapeutics SNSE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-7,535
| Closed | -$59.4K | – | 4514 |
|
2025
Q1 | $59.4K | Buy |
7,535
+91
| +1% | +$717 | ﹤0.01% | 4162 |
|
2024
Q4 | $73K | Sell |
7,444
-713
| -9% | -$6.99K | ﹤0.01% | 4171 |
|
2024
Q3 | $97.6K | Hold |
8,157
| – | – | ﹤0.01% | 4109 |
|
2024
Q2 | $101K | Buy |
8,157
+1,341
| +20% | +$16.6K | ﹤0.01% | 4140 |
|
2024
Q1 | $143K | Hold |
6,816
| – | – | ﹤0.01% | 4040 |
|
2023
Q4 | $94.4K | Hold |
6,816
| – | – | ﹤0.01% | 4202 |
|
2023
Q3 | $102K | Buy |
6,816
+1,916
| +39% | +$28.8K | ﹤0.01% | 4242 |
|
2023
Q2 | $112K | Hold |
4,900
| – | – | ﹤0.01% | 4293 |
|
2023
Q1 | $147K | Hold |
4,900
| – | – | ﹤0.01% | 4179 |
|
2022
Q4 | $146K | Buy |
4,900
+305
| +7% | +$9.09K | ﹤0.01% | 4246 |
|
2022
Q3 | $142K | Hold |
4,595
| – | – | ﹤0.01% | 4387 |
|
2022
Q2 | $208K | Sell |
4,595
-8,196
| -64% | -$371K | ﹤0.01% | 4236 |
|
2022
Q1 | $590K | Sell |
12,791
-35
| -0.3% | -$1.61K | ﹤0.01% | 3860 |
|
2021
Q4 | $1.49M | Sell |
12,826
-873
| -6% | -$101K | ﹤0.01% | 3527 |
|
2021
Q3 | $2.88M | Buy |
13,699
+6,609
| +93% | +$1.39M | ﹤0.01% | 3201 |
|
2021
Q2 | $1.38M | Buy |
7,090
+1,220
| +21% | +$238K | ﹤0.01% | 3440 |
|
2021
Q1 | $1.71M | Buy |
+5,870
| New | +$1.71M | ﹤0.01% | 3334 |
|